Omar Abughanimeh

About Omar Abughanimeh

Omar Abughanimeh, With an exceptional h-index of 10 and a recent h-index of 10 (since 2020), a distinguished researcher at University of Nebraska Medical Center, specializes in the field of Hematology/Oncology.

His recent articles reflect a diverse array of research interests and contributions to the field:

HSR24-144: Does Immunotherapy Work in Patients With Poor Performance Status?

Diagnosis of Metastatic Non-Small Cell Lung Cancer during Hospitalization: Missed Opportunity for Optimal Supportive Care?

Current management of uncommon EGFR mutations in non-small cell lung cancer

Durvalumab Outcomes in Stage III Non-small Cell Lung Cancer: A Single-institution Study

Novel Heterozygous Missense Variants in Diacylglycerol Kinase Epsilon and Complement Factor I: Potential Pathogenic Association With Atypical Hemolytic Uremic Syndrome

HSR23-102: Diagnosis of Metastatic Non–Small Cell Lung Cancer During Hospitalization: Missed Opportunity for Optimal Supportive Care?

Laboratory assays of VWF activity and use of desmopressin trials in the diagnosis of VWD: a systematic review and meta-analysis

Novel targeted therapies for advanced non-small lung cancer

Omar Abughanimeh Information

University

Position

MBBS -Fred and Pamela Buffett Cancer Center

Citations(all)

357

Citations(since 2020)

343

Cited By

130

hIndex(all)

10

hIndex(since 2020)

10

i10Index(all)

11

i10Index(since 2020)

11

Email

University Profile Page

Google Scholar

Omar Abughanimeh Skills & Research Interests

Hematology/Oncology

Top articles of Omar Abughanimeh

HSR24-144: Does Immunotherapy Work in Patients With Poor Performance Status?

Journal of the National Comprehensive Cancer Network

2024/4/5

Diagnosis of Metastatic Non-Small Cell Lung Cancer during Hospitalization: Missed Opportunity for Optimal Supportive Care?

Cancers

2024/3/20

Samia Asif
Samia Asif

H-Index: 4

Omar Abughanimeh
Omar Abughanimeh

H-Index: 5

Current management of uncommon EGFR mutations in non-small cell lung cancer

2024/2/3

Omar Abughanimeh
Omar Abughanimeh

H-Index: 5

Durvalumab Outcomes in Stage III Non-small Cell Lung Cancer: A Single-institution Study

Anticancer Research

2024/2/1

Ying Xiong
Ying Xiong

H-Index: 3

Omar Abughanimeh
Omar Abughanimeh

H-Index: 5

Novel Heterozygous Missense Variants in Diacylglycerol Kinase Epsilon and Complement Factor I: Potential Pathogenic Association With Atypical Hemolytic Uremic Syndrome

Cureus

2024/1/20

HSR23-102: Diagnosis of Metastatic Non–Small Cell Lung Cancer During Hospitalization: Missed Opportunity for Optimal Supportive Care?

Journal of the National Comprehensive Cancer Network

2023/3/31

Samia Asif
Samia Asif

H-Index: 4

Omar Abughanimeh
Omar Abughanimeh

H-Index: 5

Laboratory assays of VWF activity and use of desmopressin trials in the diagnosis of VWD: a systematic review and meta-analysis

2022/6/28

Novel targeted therapies for advanced non-small lung cancer

2022/6/1

Omar Abughanimeh
Omar Abughanimeh

H-Index: 5

Apar Kishor Ganti
Apar Kishor Ganti

H-Index: 30

Hereditary Thrombophilia Testing Among Hospitalized Patients: Is It Warranted?

Cureus

2022/5/9

Sa1421: HOSPITALIZATIONS FOR ALCOHOLIC LIVER DISEASE DURING THE COVID-19 PANDEMIC INCREASED MORE FOR WOMEN, ESPECIALLY YOUNG WOMEN, COMPARED TO MEN.

Gastroenterology

2022/5/1

Muhammad Shafiq
Muhammad Shafiq

H-Index: 10

Omar Abughanimeh
Omar Abughanimeh

H-Index: 5

Surgical management of patients with von Willebrand disease: summary of 2 systematic reviews of the literature

2022/1/11

von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis

2022/1/11

Bleeding assessment tools in the diagnosis of von Willebrand disease: systematic review & meta-analysis of test accuracy.

2021/11/1

S2816 Tumor Lysis Syndrome in a Patient With Metastatic Cholangiocarcinoma

Official journal of the American College of Gastroenterology| ACG

2021/10/1

S3564 Esophageal Rhabdomyoma: A Rare Cause of Esophageal Dysphagia

Official journal of the American College of Gastroenterology| ACG

2021/10/1

Current Management of Refractory Germ Cell Tumors

2021/9

Omar Abughanimeh
Omar Abughanimeh

H-Index: 5

Can patients with advanced malignancy and poor performance status benefit from nivolumab plus ipilimumab as a palliative treatment?

2021/5/20

Bleeding assessment tools in the diagnosis of VWD in adults and children: a systematic review and meta-analysis of test accuracy

2021/12/14

Five-Year Outcomes of Chronic Red Blood Cell Exchange Transfusion Program for Patients with Sickle Cell Disease, the Experience of University of Nebraska Medical Center

Blood

2021/11/23

Omar Abughanimeh
Omar Abughanimeh

H-Index: 5

Aleh Bobr
Aleh Bobr

H-Index: 11

Outcomes of Chronic Automated RBC Exchange Program in Omaha, Nebraska 2015-2020

Blood

2020/11/5

Aleh Bobr
Aleh Bobr

H-Index: 11

Omar Abughanimeh
Omar Abughanimeh

H-Index: 5

See List of Professors in Omar Abughanimeh University(University of Nebraska Medical Center)